Ocean Transportation Intermediary License; Rescission of Order of Revocation, 46430 [E9-21680]
Download as PDF
46430
Federal Register / Vol. 74, No. 173 / Wednesday, September 9, 2009 / Notices
FEDERAL MARITIME COMMISSION
Ocean Transportation Intermediary
License; Rescission of Order of
Revocation
Notice is hereby given that the Order
revoking the following license is being
rescinded by the Federal Maritime
Commission pursuant to section 19 of
the Shipping Act of 1984 (46 U.S.C.
Chapter 409) and the regulations of the
Commission pertaining to the licensing
of Ocean Transportation Intermediaries,
46 CFR part 515.
License Number: 019597N.
Name: United Cargo International,
Inc.
Address: 30998 Huntwood Ave., #106
Hayward, CA 94544.
Order Published: FR: 07/29/09
(Volume 74, No. 144, Pg. 37711).
Sandra L. Kusumoto,
Director, Bureau of Certification and
Licensing.
[FR Doc. E9–21680 Filed 9–8–09; 8:45 am]
BILLING CODE 6730–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0372]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Environmental
Impact Considerations
AGENCY:
Food and Drug Administration,
HHS.
cprice-sewell on DSK2BSOYB1PROD with NOTICES
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the information collection contained in
FDA regulations entitled
‘‘Environmental Impact
Considerations.’’
DATES: Submit written or electronic
comments on the collection of
information by November 9, 2009.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
VerDate Nov<24>2008
15:47 Sep 08, 2009
Jkt 217001
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Berbakos, Office of
Information Management (HFA–710),
Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,
301–796–3792.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Environmental Impact
Considerations—21 CFR Part 25 (OMB
Control Number 0910–0322)—Extension
FDA is requesting OMB approval for
the reporting requirements contained in
the FDA regulation ‘‘Environmental
Impact Considerations.’’ The National
Environmental Policy Act (NEPA) (42
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
U.S.C. 4321–4347) states national
environmental objectives and imposes
upon each Federal agency the duty to
consider the environmental effects of its
actions. Section 102(2)(C) of NEPA
requires the preparation of an
environmental impact statement (EIS)
for every major Federal action that will
significantly affect the quality of the
human environment. The FDA NEPA
regulations are in part 25 (21 CFR part
25). All applications or petitions
requesting agency action require the
submission of a claim for a categorical
exclusion or an environmental
assessment (EA). A categorical
exclusion applies to certain classes of
FDA-regulated actions that usually have
little or no potential to cause significant
environmental effects and are excluded
from the requirements to prepare an EA
or EIS. Section 25.15(a) and (d) specifies
the procedures for submitting to FDA a
claim for a categorical exclusion.
Extraordinary circumstances (§ 25.21),
which may result in significant
environmental impacts, may exist for
some actions that are usually
categorically excluded. An EA provides
information that is used to determine
whether an FDA action could result in
a significant environmental impact.
Section 25.40(a) and (c) specifies the
content requirements for EAs for
nonexcluded actions.
This collection of information is used
by FDA to assess the environmental
impact of agency actions and to ensure
that the public is informed of
environmental analyses. Firms wishing
to manufacture and market substances
regulated under statutes for which FDA
is responsible must, in most instances,
submit applications requesting
approval. Environmental information
must be included in such applications
for the purpose of determining whether
the proposed action may have a
significant impact on the environment.
Where significant adverse effects cannot
be avoided, the agency uses the
submitted information as the basis for
preparing and circulating to the public
an EIS, made available through a
Federal Register document also filed for
comment at the Environmental
Protection Agency. The final EIS,
including the comments received, is
reviewed by the agency to weigh
environmental costs and benefits in
determining whether to pursue the
proposed action or some alternative that
would reduce expected environmental
impact.
Any final EIS would contain
additional information gathered by the
agency’s after the publication of the
draft EIS, a copy of or a summary of the
comments received on the draft EIS, and
E:\FR\FM\09SEN1.SGM
09SEN1
Agencies
[Federal Register Volume 74, Number 173 (Wednesday, September 9, 2009)]
[Notices]
[Page 46430]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-21680]
[[Page 46430]]
-----------------------------------------------------------------------
FEDERAL MARITIME COMMISSION
Ocean Transportation Intermediary License; Rescission of Order of
Revocation
Notice is hereby given that the Order revoking the following
license is being rescinded by the Federal Maritime Commission pursuant
to section 19 of the Shipping Act of 1984 (46 U.S.C. Chapter 409) and
the regulations of the Commission pertaining to the licensing of Ocean
Transportation Intermediaries, 46 CFR part 515.
License Number: 019597N.
Name: United Cargo International, Inc.
Address: 30998 Huntwood Ave., 106 Hayward, CA 94544.
Order Published: FR: 07/29/09 (Volume 74, No. 144, Pg. 37711).
Sandra L. Kusumoto,
Director, Bureau of Certification and Licensing.
[FR Doc. E9-21680 Filed 9-8-09; 8:45 am]
BILLING CODE 6730-01-P